Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial to Reduce IDDM in the Genetically at Risk (TRIGR): the Pilot Study

NCT00570102 is registered in ClinicalTrials.gov with University of Helsinki as lead sponsor.

NCT NCT00570102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00570102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial to Reduce IDDM in the Genetically at Risk (TRIGR): the Pilot Study
Lead sponsor
University of Helsinki
Phase
Phase 2
Overall status
Completed
Start date
February 28, 1995
Completion date
January 31, 2008
Enrollment
230 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus